Rouge Ruthénium

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Target IC₅₀: 7 µM in blocking transmembrane Ca2+ fluxes; 6 µM inhibiting K+-stimulated catecholamine secretion

Cell permeable: no

Reversible: no

Primary TargetBlocker of transmembrane Ca2+ fluxes

Product does not compete with ATP.

General description

Ruthenium: ≥35%

A blocker of transmembrane Ca²⁺ fluxes (IC₅₀ = 7 µM) that attenuates capsaicin-induced cation channel opening. Inhibits Ca²⁺-induced Ca²⁺ release from ryanodine-sensitive intracellular Ca²⁺ stores. Inhibits K⁺-stimulated catecholamine secretion (IC₅₀ = 6 µM).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Merck Index 13, 8379.Phillippe, M. and Basa, A. 1996. Biochem. Biophys. Res. Commun. 221, 656.Buratti, R., et al. 1995. Biochem. Biophys. Res. Commun. 213, 1082.Hamilton, M.G. and Lundy, P.M. 1995. J. Pharmacol. Exp. Ther. 273, 940.Gomis, A., et al. 1994. Biochem. Pharmacol. 47, 225.Stjame, P., et al. 1994. Acta Otolaryngol. 114, 651.Ma, J. 1993. J. Gen. Physiol.102, 1031.

Packaging

250 mg in Glass bottle

Warning

Toxicity: Harmful (C)